Advertisement

Burlington medical devices firm LeMaitre Vascular Inc. is closing its California manufacturing facility, consolidating the production to the company’s Burlington headquarters, and ending production and sales of its TAArget/UniFit aortic stent grafts.

LeMaitre (Nasdaq: LMAT), which makes disposable and implantable vascular devices, said in a news release that the closure of its Laguna Hills, Calif., site, which it acquired through its November 2010 buyout of LifeSpan Vascular Graft, is the company’s seventh such consolidation since 2002. The closure should save LeMaitre $400,000 per year and bring all of its manufacturing to the Burlington location, according to a statement by company chairman and CEO George W. LeMaitre.

SOURCE

Advertisement
Advertisement